Optimal planning of adaptive two-stage designs

Area of Science:

• Clinical Trials Methodology
• Biostatistics
• Pharmaceutical Research

Background:

• Adaptive designs are crucial for modern clinical trial planning.
• Non-optimal adaptive designs are frequently used despite available research on optimal two-stage designs.

Purpose of the Study:

• To advocate for and guide the application of optimal adaptive clinical trial designs.
• To demonstrate the benefits of optimizing trial designs based on objective criteria.

Main Methods:

• Exploration of optimal determination methods for two-stage adaptive designs.
• Comparison of optimal adaptive designs with conventional adaptive sample size recalculation rules.
• Evaluation of optimal group-sequential designs against optimal adaptive designs.

Main Results:

• Optimizing trial designs yields substantial benefits compared to conventional adaptive rules.
• Optimal group-sequential designs exhibit minimal performance loss relative to optimal adaptive designs in many scenarios.
• Optimal designs can be customized for specific operational needs.

Conclusions:

• Implementing optimal adaptive designs in clinical trials is highly recommended for improved outcomes.
• Optimal group-sequential designs offer a practical alternative with comparable performance.
• Customization of optimization problems allows tailoring designs to operational requirements.